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to targets regulated by translational 
repression, but additional improve-
ments are needed, possibly resulting 
in the identification of new sequence 
and structure parameters for this tar-
get class.
The two reports (Baek et al., 2008; Sel-
bach et al., 2008) have provided a wealth 
of data that will keep both experimental 
and computational biologists busy for 
some time to come. The wider applica-
tion of these powerful new approaches 
to different experimental systems will 
help to address many of the questions 
that we have raised here.
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Cellular senescence provides an intrinsic barrier to tumor development by preventing the prolif-
eration of cells that are at risk for malignant transformation. In this issue, Krizhanovsky et al. 
(2008) report that senescence is an important player not only in tumor suppression but also in the 
response of liver tissue to injury. Mammals have developed elaborate 
mechanisms to prevent disease and injury 
and to initiate healing responses should 
those prevention mechanisms fail. A good 
example of a disease-prevention mecha-
nism is cellular senescence, a state in 
which cell division is permanently arrested 
(reviewed in Collado et al., 2007). This 
phenomenon was originally discovered in 
cultured primary cells that stop proliferat-
ing after a finite number of divisions (rep-
licative senescence). We now know that 
replicative senescence is due, at least in 
part, to erosion of telomeres, which occurs 
at each cell division. Senescent cells 
have a distinct phenotype that includes 
characteristic alterations in morphology, 
gene expression patterns, and chromatin 
structure. Specific genes are known to be 
required for senescence induction, thus 
revealing the existence of a defined genetic 
program. But why would cells develop a 562 Cell 134, August 22, 2008 ©2008 Elseviemechanism to permanently halt prolifera-
tion? Findings in experimental mouse can-
cer models and with human tumor sam-
ples hinted at the answer: precancerous 
tissues are composed of senescent cells 
(reviewed in Campisi, 2005; Sharpless 
and DePinho, 2005). These observations 
led to the notion that induction of cellular 
senescence provides an intrinsic barrier 
to cancer development by preventing the 
proliferation of cells that are damaged or 
at risk for neoplastic transformation. In this 
issue, Krizhanovsky et al. (2008) add a new 
dimension to the cellular senescence story 
by demonstrating that senescence is also 
required in the normal response to injury 
in the liver.
In their original studies of the physi-
ological response to liver damage in a 
mouse model, Krizhanovsky and col-
leagues, rather surprisingly, observed 
senescent cells in the liver. In their liver r Inc.injury model, mice are treated with the 
chemical carbon tetrachloride to induce 
fibrosis, the primary response of the 
liver to injury. Fibrosis is a wound heal-
ing process characterized by the depo-
sition of extracellular matrix components 
including collagens, proteoglycans, and 
fibronectins, which help to encapsulate 
the injury site (reviewed in Friedman, 
2008). Liver fibrosis is a precursor to 
cirrhosis, a significant health problem 
caused by diverse liver-damaging agents 
such as excessive alcohol, viral hepatitis, 
and toxins. Hepatic stellate cells (HSCs) 
are the primary modulators of liver fibro-
sis and are activated following damage 
to hepatocytes, the predominant cell 
type in liver tissue. Activated HSCs are 
characterized by increased prolifera-
tion and motility and, most importantly, 
by increased synthesis of extracellular 
matrix components. Krizhanovsky et al. 
observed that within the fibrotic regions of 
carbon tetrachloride-treated mouse livers 
were cells that, based upon characteris-
tic molecular markers, had undergone 
senescence. Although senescent cells 
had been detected in cirrhotic human 
liver in other studies, these cells were 
thought to be hepatocytes (Wiemann et 
al., 2002). Krizhanovsky et al. character-
ized the senescent cells in fibrotic mouse 
livers and discovered that they were not 
hepatocytes but were HSCs, suggesting 
a possible link between cellular senes-
cence and the response to tissue injury.
It is well established that specific genes 
including the classic tumor suppressor 
genes p53 and Rb are required for senes-
cence induction. When Krizhanovsky et 
al. induced liver fibrosis in mice lacking 
an intact p53 pathway (or lacking intact 
p53 and Rb pathways), they found that 
the amount of fibrosis was substantially 
increased. This increase in fibrosis was 
accompanied by an increased number 
of activated HSCs and, significantly, a 
decreased number of senescent HSCs. 
Taken together, these results led the 
authors to conclude that induction of 
senescence limits the number of acti-
vated HSCs and thus the progression of 
fibrosis. 
The authors then showed that senes-
cence also appears to play a role in the 
resolution of fibrosis. In both human 
patients and experimental mouse mod-
els, fibrosis can be reversed following 
elimination of the liver-damaging agent. 
Krizhanovsky et al. found that during reso-
lution of fibrosis, the number of both acti-
vated and senescent HSCs decreased. 
However, in mice lacking an intact p53 (or 
p53 and Rb) pathway, fibrotic resolution 
was impaired and there was an increased 
number of activated HSCs compared to 
wild-type mice. Collectively, these obser-
vations suggest that senescence limits 
proliferation of activated HSCs, thereby 
promoting fibrotic resolution.
Intriguingly, the investigators observed 
that the senescent HSCs seem to do more 
than just stop proliferating. Expression 
profiling experiments revealed that when 
induced to undergo senescence, HSCs 
upregulate a set of genes encoding pro-
teins that enhance immune surveillance. 
Indeed, immune modulatory cells includ-
ing natural killer (NK) cells were found 
to accumulate in the fibrotic regions of figure 1. Initiation and Resolution of Liver fibrosis
In response to injury to liver hepatocytes, a second type of liver cell, the HSC (hepatic stellate cell), be-
comes activated. Increased proliferation of HSCs and their synthesis of extracellular matrix (ECM) com-
ponents results in a wound healing response called fibrosis, which helps to contain the initial site of injury. 
After the initial damage response, activated HSCs then undergo senescence, thus limiting the amount of 
fibrosis. In addition, as they undergo senescence, HSCs attract natural killer (NK) cells to fibrotic areas, 
which results in the elimination of HSCs and the resolution of fibrosis.the mouse liver. These observations led 
the authors to propose that the senes-
cent HSCs are responsible for attract-
ing immune modulatory cells to fibrotic 
areas. In previous work, these investiga-
tors had established that liver carcinoma 
cells induced to undergo senescence 
were cleared by NK cells, leading to tumor 
regression (Xue et al., 2007). This finding 
prompted them to analyze the role of NK 
cells in eliminating senescent HSCs from 
fibrotic liver tissue. They found that mice 
depleted of NK cells by the addition of 
an NK cell-specific neutralizing antibody 
were unable to eliminate senescent HSCs 
or to resolve fibrosis. Thus, senescent 
HSCs not only permanently arrest their 
own growth but also orchestrate their 
own elimination by attracting NK cells. 
The results of Krizhanovsky et al. sug-
gest a model (Figure 1) in which a single 
cell type senses tissue damage and directs 
both the response to the damage and the 
subsequent resolution of the response. 
Upon liver damage, HSCs become acti-
vated and proliferate to mediate the fibrotic 
response to injury before eventually suc-
cumbing to senescence and clearance, in 
this way protecting the liver from exces-
sive fibrogenesis. According to this model, 
senescence both limits the expansion of 
cells responsible for fibrosis and induces 
a gene expression program that signals 
clearance of the senescent cells. Cell 13As always, new findings raise new 
questions. Perhaps the most intriguing 
question is how senescence is initiated 
in activated HSCs. The authors provide a 
compelling argument that in the relatively 
short timeframe of HSC activation in their 
experimental mouse model, it is unlikely 
that the induction of senescence is due 
to excessive HSC replication. Moreover, 
mice have unusually long telomeres that 
provide a barrier to replicative senes-
cence. One possible mechanism for HSC 
senescence is provided by an earlier study 
in which expression of an activated BRAF 
oncogene in primary melanocytes resulted 
in an initial proliferative burst followed by 
senescence induction (Michaloglou et al., 
2005). Krizhanovsky et al. speculate that 
as is the case with the BRAF-expressing 
melanocytes, some trigger such as Akt 
kinase signaling may induce an initial burst 
of HSC hyperproliferation. Indeed, the 
authors detected activated Akt in HSCs 
from fibrotic mouse liver and in senescent 
human HSCs in culture. Another important 
question pertains to how these new results 
can be reconciled with previous observa-
tions that HSCs undergo programmed 
cell death (apoptosis) during regression of 
liver fibrosis (reviewed in Elsharkawy et al., 
2005). One possibility is that apoptosis is 
an independent, secondary mechanism 
by which HSCs are cleared during fibrotic 
regression. Alternatively, HSC apoptosis 4, August 22, 2008 ©2008 Elsevier Inc. 563
may not be truly independent but rather an 
intrinsic part of the senescence pathway 
described by Krizhanovsky et al. Intrigu-
ingly, NK cells, which are attracted by the 
senescent HSCs, can induce apoptosis of 
many cell types including HSCs (Radaeva 
et al., 2006). It remains to be seen whether 
this new model is specific to liver fibrosis 
or whether it represents a more general 
homeostatic mechanism involved in other 
wound healing responses. Regardless, 
this new study clearly demonstrates that 
the role of cellular senescence extends far 
beyond cancer prevention.564 Cell 134, August 22, 2008 ©2008 Elsev
Mature cytoplasmic messenger RNAs 
(mRNAs) ready for translation are the 
products of a complex maturation path-
way that starts concomitantly with tran-
scription in the nucleus and includes 
nuclear pre-mRNA processing, mRNA 
export through nuclear pore complexes 
(NPCs), and remodeling of mRNA-ribo-
nucleoprotein (mRNP) complexes in the 
cytoplasm. Recently, it has become clear 
that many of the consecutive events in 
this pathway are tightly interconnected, 
and the number of factors that influence 
multiple distinct steps in the mRNP bio-
genesis pathway is steadily increas-
ing. New work by Bolger et al. (2008) in 
this issue now explores a fresh twist on 
the double duty carried out by proteins 
involved in mRNP biogenesis, in this case 
the role of the mRNA export factor Gle1 in 
translation initiation and termination.
Successful export of an mRNA first 
requires the association of the mRNA 
with proteins in the nucleus to form an 
Gle1 Does Dou
Ulrike Kutay1,* and Vikram Govind Pans
1Institute of Biochemistry, ETH Zurich, Schafm
*Correspondence: ulrike.kutay@bc.biol.ethz.c
DOI 10.1016/j.cell.2008.08.009
During nuclear export, Gle1 (th
DEAD-box protein Dbp5 to remo
of the nuclear pore complex. In 
in translation initiation and termiRefeRences
Campisi, J. (2005). Science 309, 886–887.
Collado, M., Blasco, M.A., and Serrano, M. (2007). 
Cell 130, 223–233.
Elsharkawy, A.M., Oakley, F., and Mann, D.A. 
(2005). Apoptosis 10, 927–939.
Friedman, S.L. (2008). Gastroenterology 134, 
1655–1669.
Krizhanovsky, V., Yon, M., Dickins, R.A., Hearn, S., 
Simon, J., Miething, C., Yee, H., Zender, L., and 
Lowe, S.W. (2008). Cell, this issue.
Michaloglou, C., Vredeveld, L.C., Soengas, M.S., ier Inc.
export-competent mRNP. Recognition of 
this mRNP by the nuclear export receptor 
Mex67 (TAP/NXF1 in vertebrates) is then 
needed to facilitate mRNP translocation 
through NPCs. In addition, several other 
factors are necessary to ensure efficient 
mRNA export. Two such essential pro-
teins are the mRNA export factor Gle1 
and its partner Dbp5 (for review, see 
Cole and Scarcelli, 2006). Dbp5 belongs 
to the family of DEAD-box-containing 
RNA helicases, which use the energy of 
ATP binding and hydrolysis to rearrange 
RNA structures or to dissociate proteins 
from RNA. Under steady-state condi-
tions, a pool of both Dbp5 and Gle1 is 
strategically positioned on the cytoplas-
mic fibrils of the NPC to remodel mRNPs 
as soon as they emerge from the NPC 
channel. Elegant previous studies in the 
budding yeast Saccharomyces cerevi-
siae revealed that the low intrinsic, RNA-
dependent ATPase activity of Dbp5 is 
greatly stimulated by NPC-associated 
ble Duty
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hexakisphosphate (IP6) (Alcazar-Roman 
et al., 2006; Weirich et al., 2006). This 
control of Dbp5 activation by Gle1 (and 
IP6), which is thought to be locally cou-
pled to the NPC, is critical for efficient 
mRNA export. It is also involved in mRNP 
remodeling events such as the disso-
ciation of the RNA-binding protein Nab2 
(Tran et al., 2007) and the export receptor 
Mex67 (Lund and Guthrie, 2005), which 
may contribute to the directionality of the 
mRNA export process.
In addition to the pools of Dbp5 and 
Gle1 attached to the NPC, both proteins 
are also found in the cytoplasm. Recent 
work in budding yeast has revealed a sur-
prising cytoplasmic role for yeast Dbp5 
in the termination of translation (Gross et 
al., 2007). Translation termination occurs 
through recognition of a stop codon in 
the ribosomal A site by the polypep-
tide release factor eRF1, which together 
with eRF3 stimulates polypeptidyl-tRNA 
A export factor) activates the 
plexes on the cytoplasmic face 
 report additional roles for Gle1 
